Cargando…

Cyclo-Oxygenase 2 Modulates Chemoresistance in Breast Cancer Cells Involving NF-κB

Background: Breast cancer cells can develop chemoresistance after prolonged exposure to cytotoxic drugs due to expression of the multi drug resistance (MDR) 1 gene. Type 2 cyclo-oxygenase (COX-2) inhibitors reverse the chemoresistance phenotype of a medullary thyroid carcinoma cell line, TT, and of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zatelli, Maria Chiara, Molè, Daniela, Tagliati, Federico, Minoia, Mariella, Ambrosio, Maria Rosaria, Uberti, Ettore Degli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2009
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619115/ https://www.ncbi.nlm.nih.gov/pubmed/19940361 http://dx.doi.org/10.3233/CLO-2009-0490

Ejemplares similares

miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase Cδ
por: Gentilin, Erica, et al.
Publicado: (2013)

Correction: Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines
por: Tagliati, Federico, et al.
Publicado: (2013)

Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines
por: Tagliati, Federico, et al.
Publicado: (2013)

Role of Pituitary Tumour Transforming Gene 1 in Medullary Thyroid Carcinoma
por: Zatelli, Maria Chiara, et al.
Publicado: (2010)

A Novel Germline CDKN1B Mutation Causing Multiple Endocrine Tumors: Clinical, Genetic and Functional Characterization
por: Molatore, Sara, et al.
Publicado: (2010)

IGF-I Influences Everolimus Activity in Medullary Thyroid Carcinoma
por: Gentilin, Erica, et al.
Publicado: (2015)

HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis
por: Caselli, Elisabetta, et al.
Publicado: (2017)

Cyclooxygenase-1-selective inhibitor SC-560
por: Long, Sihui, et al.
Publicado: (2009)

Neoadjuvant PRRT for advanced pNEN: an unusual highlander
por: Zanata, Isabella, et al.
Publicado: (2021)

EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?
por: Di Vito Nolfi, Mauro, et al.
Publicado: (2022)

Virologic and Immunologic Evidence Supporting an Association between HHV-6 and Hashimoto's Thyroiditis
por: Caselli, Elisabetta, et al.
Publicado: (2012)

Comparative QSAR analysis of cyclo-oxygenase2 inhibiting drugs
por: Mohanapriya, Arumugam, et al.
Publicado: (2012)

Chemoresistance in H-Ferritin Silenced Cells: The Role of NF-κB
por: Aversa, Ilenia, et al.
Publicado: (2018)

Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience
por: Gagliardi, Irene, et al.
Publicado: (2022)

NF-κB is a Critical Mediator of BRCA1 induced Chemoresistance
por: Harte, Mary T, et al.
Publicado: (2013)

Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget
por: Gagliardi, Irene, et al.
Publicado: (2021)

Long-term low-dose tolvaptan efficacy and safety in SIADH
por: Bondanelli, Marta, et al.
Publicado: (2023)

PPFIBP1 activates NF-κB signaling to enhance chemoresistance of multiple myeloma
por: Deng, Yi, et al.
Publicado: (2023)

NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer
por: Özeş, Ali R., et al.
Publicado: (2016)

EGF-R is Expressed and AP-1 and NF-κ:B Are Activated in Stromal Myofibroblasts Surrounding Colon Adenocarcinomas Paralleling Expression of COX-2 and VEGF
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2007)

Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer
por: Connolly, E M, et al.
Publicado: (2002)

Specific desensitization of the canine renal vasculature to angiotensin II despite cyclo-oxygenase inhibition.
por: Meggs, L. G., et al.
Publicado: (1985)

Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity
por: Jones, D J L, et al.
Publicado: (2004)

Induction of Peroxiredoxin 1 by Hypoxia Regulates Heme Oxygenase-1 via NF-κB in Oral Cancer
por: Zhang, Min, et al.
Publicado: (2014)

Cytogenetic Evolution of Human Ovarian Cell Lines Associated with Chemoresistance and Loss of Tumorigenicity
por: Struski, Stéphanie, et al.
Publicado: (2003)

Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer
por: Leung, W K, et al.
Publicado: (2001)

The association between cyclo-oxygenase-2 expression and cell proliferation and angiogenesis in human breast cancer
por: Kirkpatrick, K, et al.
Publicado: (2001)

Heme Oxygenase-1 Inhibits the Proliferation of Hepatic Stellate Cells by Activating PPARγ and Suppressing NF-κB
por: Yang, Hui, et al.
Publicado: (2022)

Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational study
por: Marcucci, Gemma, et al.
Publicado: (2021)

Molecular Network Analysis of T-Cell Transcriptome Suggests Aberrant Regulation of Gene Expression by NF-κB As a Biomarker for Relapse of Multiple Sclerosis
por: Satoh, Jun-ichi, et al.
Publicado: (2008)

Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk
por: Moore, R Andrew, et al.
Publicado: (2007)

Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells.
por: Tjandrawinata, R. R., et al.
Publicado: (1997)

The localization of cyclo-oxygenase immuno-reactivity (COX I-IR) to the urothelium and to interstitial cells in the bladder wall
por: de Jongh, R, et al.
Publicado: (2009)

Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage
por: Mirabito Colafella, Katrina M., et al.
Publicado: (2022)

Neck paraganglioma and follicular lymphoma: a case report
por: Marchetti, Lara, et al.
Publicado: (2019)

Hypeprolactinemia: still an insidious diagnosis
por: Aliberti, Ludovica, et al.
Publicado: (2020)

Cytoprotective Role of Heme Oxygenase-1 in Cancer Chemoresistance: Focus on Antioxidant, Antiapoptotic, and Pro-Autophagy Properties
por: Wang, Huan, et al.
Publicado: (2023)

Retracted: Heme Oxygenase-1 Inhibits the Proliferation of Hepatic Stellate Cells by Activating PPARγ and Suppressing NF-κB
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells
por: Basu, Gargi D, et al.
Publicado: (2005)

Use of Cyclo-Oxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study
por: Hensley, Abigail, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p15fi43gotihsghqueq8e7ghrj